1. Hosseini A, Gharibi T, Mohammadzadeh A, Ebrahimi-Kalan A, Jadidi-Niaragh F, Babaloo Z, et al. Ruxolitinib attenuates experimental autoimmune encephalomyelitis (EAE) development as animal models of multiple sclerosis (MS). Life Sci. 2021;276:119395.
2. Dema M, Eixarch H, Villar LM, Montalban X, Espejo C. Immunosenescence in multiple sclerosis: The identification of new therapeutic targets. Autoimmun Rev. 2021:102893.
3. Aghaie T, Jazayeri MH, Avan A, Anissian A, Salari AA. Gold nanoparticles and polyethylene glycol alleviate clinical symptoms and alter cytokine secretion in a mouse model of experimental autoimmune encephalomyelitis. IUBMB life. 2019;71(9):1313-21.
4. Zozulya AL, Wiendl H. The role of regulatory T cells in multiple sclerosis. Nat Clin Pract Neurol. 2008;4(7):384-98.
5. Nosratabadi R, Rastin M, Sankian M, Haghmorad D, Mahmoudi M. Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells. Nanomedicine. 2016;12(7):1961-71.
6. Aharoni R, Eilam R, Stock A, Vainshtein A, Shezen E, Gal H, et al. Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing–remitting or chronic EAE. J Neuroimmunol. 2010;225(1-2):100-11.
7. Taghizadeh S, Motallebnezhad M, Aghaie T, Azimi M, Aghamajidi A, Salari A-A, et al. Anti-Caspr-conjugated gold nanoparticles emergence as a novel approach in the treatment of EAE animal model. Metab Brain Dis. 2022.
8. Pashangzadeh S, Motallebnezhad M, Vafashoar F, Khalvandi A, Mojtabavi N. Implications the Role of miR-155 in the Pathogenesis of Autoimmune Diseases. Front Immunol. 2021;12:1645.
9. Azimi M, Ghabaee M, Moghadasi AN, Noorbakhsh F, Izad M. Immunomodulatory function of Treg-derived exosomes is impaired in patients with relapsing-remitting multiple sclerosis. Immunol Res. 2018;66(4):513-20.
10. Azimi M, Ghabaee M, Moghadasi AN, Izad M. Altered expression of miR-326 in T cell-derived exosomes of patients with relapsing-remitting multiple sclerosis. Iran J Allergy Asthma Immunol. 2019:108-13.
11. Du C, Liu C, Kang J, Zhao G, Ye Z, Huang S, et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol. 2009;10(12):1252-9.
12. Villoslada P, Steinman L. New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis. Expert Opin Investig Drugs. 2020;29(5):443-59.
13. Engler JB, Heckmann NF, Jäger J, Gold SM, Friese MA. Pregnancy enables expansion of disease-specific regulatory T cells in an animal model of multiple sclerosis. J Immunol. 2019;203(7):1743-52.
14. Jazayeri MH, Nedaeinia R, Aghaie T, Motallebnezhad M. Human placental extract attenuates neurological symptoms in the experimental autoimmune encephalomyelitis model of multiple sclerosis-a putative approach in MS disease? Auto Immun Highlights. 2020;11(1):1-9.
15. Langer-Gould A, Garren H, Slansky A, Ruiz PJ, Steinman L. Late pregnancy suppresses relapses in experimental autoimmune encephalomyelitis: Evidence for a suppressive pregancy-related serum factor. J Immunol. 2002;169(2):1084-91.
16. Gatson NN, Williams JL, Powell ND, McClain MA, Hennon TR, Robbins PD, et al. Induction of pregnancy during established EAE halts progression of CNS autoimmune injury via pregnancy-specific serum factors. J Neuroimmunol. 2011;230(1-2):105-13.
17. Williams JL, Gatson NN, Smith KM, Almad A, McTigue DM, Whitacre CC. Serum exosomes in pregnancy-associated immune modulation and neuroprotection during CNS autoimmunity. Expert Rev Clin Immunol. 2013;149(2):236-43.
18. Tastan B, Tarakcioglu E, Birinci Y, Park Y, Genc S. Role of exosomal microRNAs in cell-to-cell communication. Methods Mol Biol; 2022. p. 269-92.
19. Clark K, Zhang S, Barthe S, Kumar P, Pivetti C, Kreutzberg N, et al. Placental mesenchymal stem cell-derived extracellular vesicles promote myelin regeneration in an animal model of multiple sclerosis. Cells. 2019;8(12):1497.
20. Liu J, Luo S, Yang J, Ren F, Zhao Y, Luo H, et al. The protective effect of sheep placental extract on concanavalin A-induced liver injury in mice. Molecules. 2019;24(1):28.
21. Tiwary S, Shukla D, Tripathi A, Agrawal S, Singh M, Shukla V. Effect of placental-extract gel and cream on non-healing wounds. J Wound Care. 2006;15(7):325-8.
22. Kim BY, Park HR, Shin JH, Kim SW, Kim SW. Human placental extract reduces allergic inflammation in a murine allergic rhinitis model. Laryngoscope. 2014;124(10):E399-E404.
23. Park JD, Lee S-I, Kim AR, Park JM, Shin S-Y, Shin JH, et al. The effect of human placental extract on rheumatoid arthritis in an animal model. Ann Rehabil Med. 2012;36(2):197.
24. Voisin JE, Kinsky RG, Voisin GA. Maternal alloimmune reactions towards the murine conceptus and graft-versus-host reaction (GVHR) II. Inhibition of priming by placental extracts. J Reprod Immunol. 1986;9(2):85-94.
25. Park JY, Byeon JH, Park S-W, Eun S-H, Chae KY, Eun B-L. Neuroprotective effect of human placental extract on hypoxic–ischemic brain injury in neonatal rats. Brain & development. 2013;35(1):68-74.
26. de Toledo A, Nomoto K, Hirano E, Tohda C. Horse Placental Extract Enhances Neurogenesis in the Presence of Amyloid β. Nutrients. 2021;13(5):1672.
27. Poletaev A, Arapov N. Rehabilitation of patients after stroke: new remedy? Pharmacology. 2006;3:73-9.
28. Skehel JM. Preparation of extracts from animal tissues. Methods Mol Biol. 2004. p. 15-20.
29. Majidi-Zolbanin J, Doosti M-H, Kosari-Nasab M, Salari A-A. Prenatal maternal immune activation increases anxiety-and depressive-like behaviors in offspring with experimental autoimmune encephalomyelitis. Neuroscience. 2015;294:69-81.
30. Begum-Haque S, Christy M, Ochoa-Reparaz J, Nowak EC, Mielcarz D, Haque A, et al. Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate. J Neuroimmunol. 2011;232(1-2):136-44.
31. Begum-Haque S, Sharma A, Kasper IR, Foureau DM, Mielcarz DW, Haque A, et al. Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2008;204(1-2):58-65.
32. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3(6):1101-8.
33. Ramakrishnan K, Jayaraman V. Management of partial-thickness burn wounds by amniotic membrane: a cost-effective treatment in developing countries. Burns. 1997;23:S33-S6.
34. Gold-Aubert P, Chaumontet M, Capt M. An experimental study of the anti-inflammatory and anti-arthritic properties of a standardized placental extract. Int J Tissue React. 1981;3(3-4):155-65.
35. Rosenthal M. The application of an extract of human placenta in the treatment of rheumatic affections. Int J Tissue React. 1982;4(2):147-51.
36. LUBOWE II. TOPICAL USE OF PLACENTA‐EXTRACT GEL (NON‐ESTROGENIC) IN THE TREATMENT OF AGING SKIN. J Am Geriatr Soc. 1963;11(9):914-7.
37. Biswas T, Auddy B, Bhattacharya N, Bhattacharya S, Mukherjee B. Wound healing activity of human placental extracts in rats. Acta Pharmacol Sin. 2001;22(12):1113-6.
38. Van Walderveen M, Tas M, Barkhof F, Polman C, Frequin S, Hommes O, et al. Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis. Neurology. 1994;44(2):327-.
39. Gregg C, Shikar V, Larsen P, Mak G, Chojnacki A, Yong VW, et al. White matter plasticity and enhanced remyelination in the maternal CNS. J Neurosci. 2007;27(8):1812-23.
40. Jadidi‐Niaragh F, Mirshafiey A. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol. 2011;74(1):1-13.